| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $4.8M | — | +15.0% |
| SG&A Expense | $5.1M | — | +56.3% |
| Operating Income | -$9.9M | — | -33.1% |
| Pre-tax Income | -$9.6M | — | -42.7% |
| Income Tax | $0 | — | — |
| Net Income | -$9.6M | — | -42.7% |
| EPS (Basic) | -$1.11 | — | -2120.0% |
| EPS (Diluted) | -$1.11 | — | -2120.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31.7M | -23.2% | -51.3% |
| Current Assets | $36.7M | -19.6% | -46.7% |
| Total Assets | $37.9M | -20.3% | -46.4% |
| Current Liabilities | $7.5M | -9.7% | +37.5% |
| Total Liabilities | $7.5M | -9.7% | +37.5% |
| Stockholders' Equity | $30.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.6M | — | -60.8% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $0 | — | — |
| Free Cash Flow | -$9.6M | — | -60.5% |
| -53.3% |